Although CDK6 and STAT5B are established oncogenic drivers, how they cooperate during lymphoma initiation remains poorly understood. The authors show that combined Cdk6 and Stat5b deletion completely prevents ALK-driven anaplastic large cell lymphoma (ALCL) tumorigenesis, and suggest a prognostic signature linked to poor outcome in ALCL.